Lifeward Ltd.
LFWDNASDAQHealthcare● Active
$6.98
$-0.03(-0.36%)
Market Cap$11244787
P/E Ratio—
52W High$15
52W Low$4.14
Lifeward Ltd. (LFWD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LFWD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$6.70
Est. -$0.34 · -1870.6%
Revenue
$0.00B
Est. $0.01B · -32.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
LFWD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$1.39 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 15, 2026 | -$0.34 | -$6.70 | -1870.6% | $0.00B | $0.01B | -32.1% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -$0.84 | -$3.60 | -328.6% | $0.01B | $0.01B | -35.4% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$0.09 | -$0.20 | -122.2% | $0.01B | $0.01B | -21.3% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.25 | -$0.58 | -132.0% | $0.01B | $0.01B | -13.5% |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.33 | -$0.46 | -39.4% | $0.01B | $0.01B | -23.9% |
| ▼ Q1 FY2025 | Mar 7, 2025 | -$0.20 | -$0.38 | -90.0% | $0.01B | $0.01B | +0.2% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.27 | -$0.45 | -66.7% | $0.01B | $0.01B | -16.0% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$1.39
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026Miss
EPS Actual
-$6.70
EPS Est.
-$0.34
EPS Surpr.
-1870.6%
Revenue
$0.00B
Q1 FY2026
Mar 18, 2026Miss
EPS Actual
-$3.60
EPS Est.
-$0.84
EPS Surpr.
-328.6%
Revenue
$0.01B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.09
EPS Surpr.
-122.2%
Revenue
$0.01B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.58
EPS Est.
-$0.25
EPS Surpr.
-132.0%
Revenue
$0.01B
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.46
EPS Est.
-$0.33
EPS Surpr.
-39.4%
Revenue
$0.01B
Q1 FY2025
Mar 7, 2025Miss
EPS Actual
-$0.38
EPS Est.
-$0.20
EPS Surpr.
-90.0%
Revenue
$0.01B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.45
EPS Est.
-$0.27
EPS Surpr.
-66.7%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.63 | $-0.54 | $-0.44 | 1 |
| Q3 FY2027 | $-0.54 | $-0.46 | $-0.38 | 1 |
| Q2 FY2027 | $-0.46 | $-0.39 | $-0.33 | 1 |
| Q1 FY2027 | $-0.39 | $-0.33 | $-0.27 | 1 |
| Q4 FY2026 | $-0.67 | $-0.58 | $-0.48 | 1 |
| Q3 FY2026 | $-0.79 | $-0.68 | $-0.56 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 15, 2026 | -1870.6% | $6.60 | $6.70 | +1.52% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -328.6% | $7.56 | $6.72 | -11.11% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -122.2% | $6.25 | $7.18 | +14.88% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -132.0% | $8.60 | $7.34 | -14.65% |
| ▼ Q2 FY2025 | May 15, 2025 | -39.4% | $17.28 | $15.48 | -10.42% |
| ▼ Q1 FY2025 | Mar 7, 2025 | -90.0% | $18.96 | $19.56 | +3.16% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -66.7% | $28.44 | $28.68 | +0.84% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +9.1% | $38.04 | $37.44 | -1.58% |
Q2 FY2026+1.52%
Report Date
May 15, 2026
EPS Beat/Miss
-1870.6%
Price Before
$6.60
Price After
$6.70
Q1 FY2026-11.11%
Report Date
Mar 18, 2026
EPS Beat/Miss
-328.6%
Price Before
$7.56
Price After
$6.72
Q4 FY2025+14.88%
Report Date
Nov 14, 2025
EPS Beat/Miss
-122.2%
Price Before
$6.25
Price After
$7.18
Q3 FY2025-14.65%
Report Date
Aug 14, 2025
EPS Beat/Miss
-132.0%
Price Before
$8.60
Price After
$7.34
Q2 FY2025-10.42%
Report Date
May 15, 2025
EPS Beat/Miss
-39.4%
Price Before
$17.28
Price After
$15.48
Q1 FY2025+3.16%
Report Date
Mar 7, 2025
EPS Beat/Miss
-90.0%
Price Before
$18.96
Price After
$19.56
Q4 FY2024+0.84%
Report Date
Nov 12, 2024
EPS Beat/Miss
-66.7%
Price Before
$28.44
Price After
$28.68
Q3 FY2024-1.58%
Report Date
Aug 14, 2024
EPS Beat/Miss
+9.1%
Price Before
$38.04
Price After
$37.44
Avg Beat Reaction-1.58%
Avg Miss Reaction-2.25%
Beat Rate1 / 8 quarters
Largest Move+14.88% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LFWD ends December
Lifeward Ltd. (LFWD) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-6.70 — missing the analyst consensus of $-0.34 by -1870.6%. The next LFWD earnings date is expected around September 1, 2026.
Each quarter, investors track LFWD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LFWD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LFWD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LFWD earnings · 5 questionsLifeward Ltd.'s next earnings report is expected around September 1, 2026. LFWD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LFWD historically reports after market close (AMC).
LFWD earnings datewhen is LFWD earningsLFWD next earnings datewhen does LFWD report earningsLFWD earnings calendar
▸ Source: FMP · Lifeward Ltd. SEC filings · US GAAP · Lifeward Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026